Clinical trial · Interventional
Translating Healthy Lifestyle Interventions for Cancer Survivors
Translating Healthy Lifestyle Interventions for Breast and Endometrial Cancer Survivors With Diabetes
NCT02690766CI-TRIAL-00066443completedN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
Investigators proposed to refine and test the feasibility and acceptability of a 4-month multi-modal lifestyle intervention in African American female breast or endometrial cancer survivors diagnosed with type 2 diabetes.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Breast Cancer | Malignant Breast Neoplasm | CURATED_EXACT | 0.92 |
| Diabetes Mellitus, Non-Insulin-Dependent | — | UNRESOLVED | — |
| Endometrial Cancer | Malignant Endometrial Neoplasm | CURATED_BROADER | 0.80 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Standard Behavioral Weight Change Intervention | Behavioral | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- OTHER
- label
- Physical Activity Group
- description
- The Success Study's Standard Behavioral Weight Change Intervention consists of 75 minute group sessions held monthly which include 30 minutes of physical activity with a licensed Physical Activity Instructor. Web Lessons that include information on Physical Activity, Nutrition and Healthy Behaviors will also be provided to participants on the study's website.
- interventionNames
- Behavioral: Standard Behavioral Weight Change Intervention
Primary outcomes (1)
- measure
- Change in Body Weight
- timeFrame
- Week 0 and 16
- description
- Body weight in pounds will be measured on a digital scale to assess change in body weight over the 16-week intervention period
Eligibility
Eligibility (as posted)
- Sex
- Female
- Minimum age
- 30 Years
- Maximum age
- 99 Years
Show eligibility criteria text
Inclusion Criteria: * African American women, ages 30 * No evidence of pregnancy, as evidenced by negative urine pregnancy test. * Diagnosed with type 2 diabetes by their provider * Diagnosed with Stage I-III breast or endometrial cancer * Completed treatment for breast or endometrial cancer at least 4 months and no more 5 years ago English-speaking * Agree to participate in all aspects of the semi-structured interview (Aim 1) * Agree to participate in all aspects of the feasibility study, including group sessions (Aim 2) * Access to the internet via phone or computer * Access to a working phone for personal use Exclusion Criteria: * Non-English speaking * Recent epilepsy, cardiac event or stroke in last 6 months,special nutritional needs (e.g. current evidence of malignancy; HIV) * History of epilepsy, cardiac event or stroke within the last year * Known diagnosis of HIV * Known new malignancy * Less than 4 months or more than 2 years post treatment of Stage I-III breast or endometrial cancer. * No diagnosis of type 2 diabetes * No self-report of African American race/ethnicity * No access to a phone for personal use * No access to the internet via computer or mobile phone
References
Publications (0)
Data not yet available
No reference posted for this study.